tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OLMA Stock Latest News

Olema Oncology initiated with a Buy at Guggenheim
The FlyOlema Oncology initiated with a Buy at Guggenheim
1d ago
OLMA
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ESR1 Patient Treatment Drives Buy Rating
PremiumRatings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ESR1 Patient Treatment Drives Buy Rating
13d ago
OLMA
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
PremiumThe Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
17d ago
CHRO
OLMA
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
PremiumThe Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
17d ago
CHRO
OLMA
Olema Pharmaceuticals: Strategic Positioning and Promising Outlook in the Oral SERD Market
PremiumRatings
Olema Pharmaceuticals: Strategic Positioning and Promising Outlook in the Oral SERD Market
21d ago
OLMA
Oppenheimer says Olema collaboration with Pfizer could lead to bidding war
PremiumThe FlyOppenheimer says Olema collaboration with Pfizer could lead to bidding war
1M ago
NVS
PFE
Buy Recommendation for Olema Pharmaceuticals Driven by Strategic Collaborations and Promising Clinical Developments
Premium
Ratings
Buy Recommendation for Olema Pharmaceuticals Driven by Strategic Collaborations and Promising Clinical Developments
1M ago
OLMA
Strategic Collaboration with Pfizer Boosts Olema Pharmaceuticals’ Prospects in ER+ Breast Cancer Treatment
Premium
Ratings
Strategic Collaboration with Pfizer Boosts Olema Pharmaceuticals’ Prospects in ER+ Breast Cancer Treatment
1M ago
OLMA
Olema Pharmaceuticals Partners with Pfizer for New Trial
PremiumCompany Announcements
Olema Pharmaceuticals Partners with Pfizer for New Trial
1M ago
8K
OLMA
Olema Oncology announces new trial agreement with Pfizer
PremiumThe Fly
Olema Oncology announces new trial agreement with Pfizer
1M ago
PFE
OLMA
Olema Pharmaceuticals: Strategic Advancements and Market Potential in Oncology Drive Buy Rating
PremiumRatings
Olema Pharmaceuticals: Strategic Advancements and Market Potential in Oncology Drive Buy Rating
2M ago
OLMA
Promising Efficacy and Strategic Partnerships Drive Buy Rating for Olema Pharmaceuticals
PremiumRatings
Promising Efficacy and Strategic Partnerships Drive Buy Rating for Olema Pharmaceuticals
2M ago
OLMA
Citi ups Olema target, adds ‘upside catalyst watch’
PremiumThe FlyCiti ups Olema target, adds ‘upside catalyst watch’
2M ago
OLMA
Olema Pharmaceuticals Advances Breast Cancer Therapies
Premium
Company Announcements
Olema Pharmaceuticals Advances Breast Cancer Therapies
2M ago
OLMA
Olema Pharmaceuticals: Promising Advancements in ER+ Breast Cancer Treatment and Strategic Positioning Justify Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Advancements in ER+ Breast Cancer Treatment and Strategic Positioning Justify Buy Rating
2M ago
OLMA
Olema Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Olema Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
8K
OLMA
Olema Oncology reports Q2 EPS (51c), consensus (44c)
PremiumThe Fly
Olema Oncology reports Q2 EPS (51c), consensus (44c)
2M ago
OLMA
OLMA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
OLMA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
OLMA
Olema Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Olema Pharmaceuticals Holds Annual Stockholders Meeting
4M ago
8K
OLMA
Promising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals
PremiumRatingsPromising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals
4M ago
OLMA
Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook
Premium
Ratings
Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook
4M ago
OLMA
Olema Oncology announces palazestrant dose selection, trial-in-progress poster
Premium
The Fly
Olema Oncology announces palazestrant dose selection, trial-in-progress poster
4M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >